(RTTNews) - Myriad Genetics Inc. (MYGN) said that it has entered into a partnership with Gabbi, a telehealth platform specializing in breast cancer risk assessment and specialist care. The ...
Medical workforce. Reason for increased risk of pandemic abstract idea thin line illustration. Isolated outline drawing. Myriad Pro-Bold fonts used rare disease icon stock illustrations Health worker ...
SALT LAKE CITY, Feb. 24, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, and PATHOMIQ, Inc., a developer of artificial ...
(RTTNews) - Myriad Genetics, Inc. (MYGN) Monday announced the appointment of Sam Raha, the Company's current Chief Operating Officer (COO), as President and Chief Executive Officer (CEO ...
Genetic testing company Myriad Genetics (NASDAQ:MYGN) fell short of the market’s revenue expectations in Q4 CY2024, but sales rose 7.1% year on year to $210.6 million. The company’s full-year ...
SALT LAKE CITY, Feb. 24, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostics testing and precision medicine, today announced that its Board of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback